Loading...
enVVeno Medical Corporation
NVNOW•NASDAQ
HealthcareMedical - Devices
$0.006
$-0.00(-32.98%)
enVVeno Medical Corporation (NVNOW) Financial Performance & Statements
Review enVVeno Medical Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
5.59%
↑ 5.59%
Net Income Growth
7.22%
↑ 7.22%
Operating Cash Flow Growth
10.71%
↑ 10.71%
Operating Margin
-2866.63%
↓ 2866.63%
Gross Margin
17.36%
↑ 17.36%
Net Profit Margin
-2626.85%
↓ 2626.85%
ROE
-51.32%
↓ 51.32%
ROIC
-59.81%
↓ 59.81%
enVVeno Medical Corporation (NVNOW) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for enVVeno Medical Corporation stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $812000.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $406000.00 | $129000.00 | $136000.00 | $141000.00 |
| Gross Profit | $406000.00 | -$129000.00 | -$136000.00 | -$141000.00 |
| Gross Profit Ratio | $0.50 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $3.51M | $2.86M | $2.83M | $3.05M |
| SG&A Expenses | $3.46M | $3.31M | $2.49M | $2.31M |
| Operating Expenses | $6.98M | $6.17M | $5.32M | $5.36M |
| Total Costs & Expenses | $7.38M | $6.17M | $5.45M | $5.50M |
| Interest Income | $163000.00 | $94000.00 | $73000.00 | $59000.00 |
| Interest Expense | $389000.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | -$406000.00 | $129000.00 | $136000.00 | $141000.00 |
| EBITDA | -$6.73M | -$6.04M | -$5.32M | -$5.36M |
| EBITDA Ratio | -$8.29 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$6.70M | -$6.17M | -$5.45M | -$5.50M |
| Operating Income Ratio | -$8.25 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | $470000.00 | $528000.00 | $498000.00 | $511000.00 |
| Income Before Tax | -$6.23M | -$5.64M | -$4.96M | -$4.99M |
| Income Before Tax Ratio | -$7.67 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | -$97724.00 | $0.00 | $0.00 | $97724.00 |
| Net Income | -$6.23M | -$5.64M | -$4.96M | -$4.99M |
| Net Income Ratio | -$7.67 | $0.00 | $0.00 | $0.00 |
| EPS | $0.91 | -$0.35 | -$0.31 | -$0.31 |
| Diluted EPS | $0.91 | -$0.35 | -$0.31 | -$0.31 |
| Weighted Avg Shares Outstanding | $17.14M | $16.07M | $16.07M | $16.06M |
| Weighted Avg Shares Outstanding (Diluted) | $17.14M | $16.07M | $16.07M | $16.06M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan